Sequential Dose-escalation Study to Assess the Safety, Tolerability and Pharmacokinetics of TB006 in Healthy Subjects

Clinical trial NCT04920786 · COMPLETED

Trial details

NCT number: NCT04920786
Sponsor: TrueBinding, Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Alzheimer Disease

Start date: 2021-06-01
Primary completion: 2022-05-03
Enrollment: 48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.